A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

C J Tyrrell; A V Kaisary; P Iversen; J B Anderson; L Baert; T Tammela; M Chamberlain; A Webster; G Blackledge

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

C J Tyrrell, A V Kaisary, P Iversen, J B Anderson, L Baert, T Tammela, M Chamberlain, A Webster, G Blackledge

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

283 Citationer (Scopus)

Abstract

To evaluate the efficacy and tolerability of 'Casodex' monotherapy (150 mg daily) for metastatic and locally advanced prostate cancer.

Originalsprog	Engelsk
Tidsskrift	European Urology
Vol/bind	33
Udgave nummer	5
Sider (fra-til)	447-56
Antal sider	10
ISSN	0302-2838
Status	Udgivet - 1998

Citationsformater

@article{890aa18a6bb2403b829d89f035c93710,

title = "A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer",

abstract = "To evaluate the efficacy and tolerability of 'Casodex' monotherapy (150 mg daily) for metastatic and locally advanced prostate cancer.",

author = "Tyrrell, {C J} and Kaisary, {A V} and P Iversen and Anderson, {J B} and L Baert and T Tammela and M Chamberlain and A Webster and G Blackledge",

year = "1998",

language = "English",

volume = "33",

pages = "447--56",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer

AU - Tyrrell, C J

AU - Kaisary, A V

AU - Iversen, P

AU - Anderson, J B

AU - Baert, L

AU - Tammela, T

AU - Chamberlain, M

AU - Webster, A

AU - Blackledge, G

PY - 1998

Y1 - 1998

N2 - To evaluate the efficacy and tolerability of 'Casodex' monotherapy (150 mg daily) for metastatic and locally advanced prostate cancer.

AB - To evaluate the efficacy and tolerability of 'Casodex' monotherapy (150 mg daily) for metastatic and locally advanced prostate cancer.

M3 - Journal article

SN - 0302-2838

VL - 33

SP - 447

EP - 456

JO - European Urology

JF - European Urology

IS - 5

ER -